MarketsandMarkets

Pediatric Interventional Cardiology Market Worth $1,379.1 Million by 2018

Pediatric Interventional Cardiology Market By Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures – Global Forecasts to 2018

 

Dallas, TX -- (SBWIRE) -- 10/13/2014 -- The “Pediatric Interventional Cardiology Market by Congenital Heart Defect Closure Device [ASD, Ventricular Septal Defect, Patent Ductus Arteriosus, Left Atrial Appendage, Aortic Valve, Pulmonary Valve] & Procedures - Global Forecasts to 2018” analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, APAC, and the Rest of the World.

Browse more than 90 market data tables with 19 figures spread through 165 pages and in-depth TOC on "Pediatric Interventional Cardiology Market”
http://www.marketsandmarkets.com/Market-Reports/pediatric-interventional-cardiology-market-236831456.html

Early buyers will receive 10% customization on this report.

The global pediatric interventional cardiology market is segmented on the basis of type of devices and geography. Based on the type of device, the market is further segmented into congenital heart defect closure devices, transcatheter heart valves, and others (catheters, guidewires, balloons, and stents). Based on geography, this market is divided into four geographic regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW). This report also includes the number of pediatric interventional cardiology procedures performed across different regions.

Speak to Analyst: http://www.marketsandmarkets.com/speaktoanalyst.asp?id=236831456

The market is expected to witness a healthy growth in the forecast period. This high growth can be attributed to a number of factors such as the rising incidences of congenital heart disease and FDA’s initiatives to seep-up the regulatory procedure. Technological advancements, owing to which new and advanced products are being launched in the market, is another factor propelling the growth of this market. The untapped markets in the Asia-Pacific region are major opportunity areas for pediatric interventional cardiology companies. Limited penetration of cardiac devices which are specifically designed for pediatric patients is a major unmet need in this market; it offers a huge array of opportunities for the market to grow. However, varied stringency of regulatory procedures across the globe and the presence of complex regulatory procedures may hinder the growth of this market.

Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=236831456

The Asia-Pacific region is expected to witness the highest growth over the next five years. The major reason for this high growth is the improving healthcare infrastructure in this region. Also, the growth in government investments for improving pediatric care facilities, coupled with investments by major players in the APAC region, is another factor that is propelling the growth of this market.

The major players in the market include St. Jude Medical (U.S), Gore Medical (U.S.), Boston Scientific (U.S.), Edward LifeSciences (U.S.), Abbott Vascular (U.S.), GE Healthcare (U.S.), and Siemens Healthcare (Germany).

Browse related reports:

Diagnostic Electrocardiograph (ECG) Market by Product (Resting, Stress, Holter Monitor), End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, Nursing Homes) & by Lead Type (Single, 3-6, 12) - Global Forecast to 2020
http://www.marketsandmarkets.com/Market-Reports/Diagnostic-ECG-global-Market-173.html

Newborn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit – Global Forecast to 2019
http://www.marketsandmarkets.com/Market-Reports/newborn-screening-market-141676244.html

About MarketsandMarkets
MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304, Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets